Clinical Trials Companies

Latest Clinical Trials Companies Update

• 
  October 2023: Roche Pharma India has declared the initiation of its clinical trial excellence initiative in India, which aims to enhance the capacities of public health institutions within the nation to conduct drug research and clinical trials. This will additionally empower these public institutions to elevate themselves up the value chain and establish themselves as national hubs of clinical research excellence. Roche's initial objective for this program is to establish collaborative partnerships with ten government institutions with the purpose of advancing clinical research excellence by enhancing their current capacities to conduct trials in accordance with international benchmarks. In order to accomplish this, the research team must be trained, processes must be developed or improved, dossier submission and evaluation by the Ethics Committee must be digitized, and this will pave the way for an increase in high-quality clinical research that prioritizes patient safety and innovative treatments.

• 
  November 2023: TB Alliance initiated NC-009, a novel Pan-Phase 2 clinical trial that integrated aspects of Phase 2a, b, and c. The purpose of this trial was to assess the safety and effectiveness of TBAJ-876, a novel experimental compound, in combination with pretomanid and linezolid, which are constituents of TB Alliance's BPaL regimen. This regimen possesses the capacity to reduce treatment duration and enhance efficacy for drug-sensitive and drug-resistant tuberculosis (TB), which is among the most lethal infectious diseases on a global scale. The findings from preclinical and Phase 1 investigations that were presented at the Union Conference indicated that the novel compound exhibited a potentially safer profile and a more rapid elimination of tuberculosis bacteria in comparison to bedaquiline, another medicine in the same drug class.

• 
  

  Charles River Laboratories

  
  


• 
  

  Paraxel International Corporation

  
  


• 
  

  Quintiles IMS

  
  


• 
  

  ICON plc

  
  


• 
  

  SGS SA

  
  


• 
  

  Eli Lilly and Company

  
  


• 
  

  Novo Nordisk A/S

  
  


• 
  

  Clinipace

  
  


• 
  

  Laboratory Corporation of America

  
  


• 
  

  Pfizer